Special Reports
Slippery Slope
More in Slippery Slope
In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, ľֱ and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.
Apr 19, 2015
Makers of diet drugs spent more than $60 million on payments to doctors, organized medicine, and lobbyists to get their drugs approved.
Apr 19, 2015